Since completing the $4.9bn acquisition of Inari Medical in February 2025, Stryker's biggest growth area was in its vascular business.

Stryker (NYSE:SYK) announced a 4.8% increase in its quarterly dividend. The higher dividend highlights the Board's focus on returning cash to shareholders. The decision reflects management's view of ...

Stryker expects the robot, called Mako RPS, to bring in new customers, including more ambulatory surgery centers.

EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): With an impressive ...

Q4 2025 Management View CEO Kevin Lobo described 2025 as “outstanding for both Q4 and the full year across all key financial metrics,” with organic sales growth of 11% in Q4 and 10.3% for the year, ...

Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable April 30, 2026, to shareholders of record at the close of business on March 31, ...

Portage, Michigan, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2025: Reported net sales increased11.4% to $7.2 billion ...

Whether through pressure injury prevention, fall prevention, infection prevention or safe patient handling initiatives, Stryker’s mission is to do everything possible to provide the optimal experience ...

Stryker Corporation (NYSE:SYK) Q4 2025 Earnings Call Transcript January 29, 2026 Stryker Corporation beats earnings ...

Stryker reported an adjusted fourth-quarter earnings per share (EPS) of $4.47, beating analysts' consensus of $4.40.

Portage, MI-based Stryker gave analysts and investors quite a bit to digest this week, beginning with the news that it will be selling its U.S. spinal implants business to Viscogliosi Brothers, a ...